Think of Adlyxine and Ozempic as Similar to Victoza and Other GLP-1 Agonists

February 2018

Adlyxine (ad-LIKS-een, lixisenatide) and Ozempic (oh-ZEM-pik, semaglutide) will be the latest "GLP-1 agonists" for type 2 diabetes.

Think of these new meds as similar to Victoza and Trulicity.

They're all injections...and cost at least $120/month.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Salt Forms Know Your Way Around Salt Forms
Dispensing Optimize Use of Auxiliary Labels
Diabetes Meds Think of Adlyxine and Ozempic as Similar to Victoza and Other GLP-1 Agonists
Monitoring Help Patients With FreeStyle Libre and Other Continuous Glucose Monitors
Nausea & Vomiting Akynzeo Is the Latest Combo Oral Med for Chemo-Induced Nausea and Vomiting
Psoriasis Know Key Points About the "Biologics" Taltz and Tremfya for Psoriasis
Natural Health Products Be Aware That Biotin May Skew Lab Test Results
Natural Health Products Watch for Labelling Changes on Green Tea Extract Products
Travel Medicine Keep the Different Meds Used for Altitude Sickness Straight
Women's Health Listen for Questions About Breast Cancer Risk With Hormonal Contraceptives
Practice Get Tools to Tackle This Flu Season